These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 24584917)

  • 1. Can we decide which outcomes should be measured in every clinical trial? A scoping review of the existing conceptual frameworks and processes to develop core outcome sets.
    Idzerda L; Rader T; Tugwell P; Boers M
    J Rheumatol; 2014 May; 41(5):986-93. PubMed ID: 24584917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.
    Boers M; Kirwan JR; Gossec L; Conaghan PG; D'Agostino MA; Bingham CO; Brooks PM; Landewé R; March L; Simon L; Singh JA; Strand V; Wells GA; Tugwell P
    J Rheumatol; 2014 May; 41(5):1025-30. PubMed ID: 24584913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updating the OMERACT filter at OMERACT 11.
    Kirwan JR; Boers M; Tugwell P
    J Rheumatol; 2014 May; 41(5):975-7. PubMed ID: 24788466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a generalized framework of core measurement areas in clinical trials: a position paper for OMERACT 11.
    Boers M; Idzerda L; Kirwan JR; Beaton D; Escorpizo R; Boonen A; Magasi S; Sinha I; Stucki G; Tugwell P
    J Rheumatol; 2014 May; 41(5):978-85. PubMed ID: 24584922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.
    Boers M; Kirwan JR; Wells G; Beaton D; Gossec L; d'Agostino MA; Conaghan PG; Bingham CO; Brooks P; Landewé R; March L; Simon LS; Singh JA; Strand V; Tugwell P
    J Clin Epidemiol; 2014 Jul; 67(7):745-53. PubMed ID: 24582946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updating the OMERACT filter: implications for patient-reported outcomes.
    Kirwan JR; Bartlett SJ; Beaton DE; Boers M; Bosworth A; Brooks PM; Choy E; de Wit M; Guillemin F; Hewlett S; Kvien TK; Landewé RB; Leong AL; Lyddiatt A; March L; May J; Montie PL; Nikaï E; Richards P; Voshaar MM; Smeets W; Strand V; Tugwell P; Gossec L
    J Rheumatol; 2014 May; 41(5):1011-5. PubMed ID: 24584919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group.
    Finger ME; Boonen A; Woodworth TG; Escorpizo R; Christensen R; Nielsen SM; Leong AL; Scholte Voshaar M; Flurey CA; Milman N; Verstappen SM; Alten R; Guillemin F; Kloppenburg M; Beaton DE; Tugwell PS; March LM; Furst DE; Pohl C
    J Rheumatol; 2017 Nov; 44(11):1734-1739. PubMed ID: 28461648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments.
    Naye F; Toupin-April K; de Wit M; LeBlanc A; Dubois O; Boonen A; Barton JL; Fraenkel L; Li LC; Stacey D; March L; Barber CEH; Hazlewood GS; Guillemin F; Bartlett SJ; Berthelsen DB; Mather K; Arnaud L; Akpabio A; Adebajo A; Schultz G; Sloan VS; Gill TK; Sharma S; Scholte-Voshaar M; Caso F; Nikiphorou E; Nasef SI; Campbell W; Meara A; Christensen R; Suarez-Almazor ME; Jull JE; Alten R; Morgan EM; El-Miedany Y; Singh JA; Burt J; Jayatilleke A; Hmamouchi I; Blanco FJ; Fernandez AP; Mackie S; Jones A; Strand V; Monti S; Stones SR; Lee RR; Nielsen SM; Evans V; Srinivasalu H; Gérard T; Demers JL; Bouchard R; Stefan T; Dugas M; Bergeron F; Beaton D; Maxwell LJ; Tugwell P; Décary S
    Semin Arthritis Rheum; 2024 Apr; 65():152344. PubMed ID: 38232625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group.
    Klokker L; Tugwell P; Furst DE; Devoe D; Williamson P; Terwee CB; Suarez-Almazor ME; Strand V; Woodworth T; Leong AL; Goel N; Boers M; Brooks PM; Simon LS; Christensen R
    J Rheumatol; 2017 Dec; 44(12):1916-1919. PubMed ID: 27744393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets.
    Tunis SR; Maxwell LJ; Graham ID; Shea BJ; Beaton DE; Bingham CO; Brooks P; Conaghan PG; D'Agostino MA; de Wit MP; Gossec L; March LM; Simon LS; Singh JA; Strand V; Wells GA; Tugwell P
    J Rheumatol; 2017 Oct; 44(10):1551-1559. PubMed ID: 28765256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The World Health Organisation International Classification of Functioning, Disability and Health: a conceptual model and interface for the OMERACT process.
    Stucki G; Boonen A; Tugwell P; Cieza A; Boers M
    J Rheumatol; 2007 Mar; 34(3):600-6. PubMed ID: 17343306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes from the Patient Perspective Workshop at OMERACT 6.
    Kirwan J; Heiberg T; Hewlett S; Hughes R; Kvien T; Ahlmèn M; Boers M; Minnock P; Saag K; Shea B; Suarez Almazor M; Taal E
    J Rheumatol; 2003 Apr; 30(4):868-72. PubMed ID: 12672218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updating the OMERACT filter: core areas as a basis for defining core outcome sets.
    Kirwan JR; Boers M; Hewlett S; Beaton D; Bingham CO; Choy E; Conaghan PG; D'Agostino MA; Dougados M; Furst DE; Guillemin F; Gossec L; van der Heijde DM; Kloppenburg M; Kvien TK; Landewé RB; Mackie SL; Matteson EL; Mease PJ; Merkel PA; Ostergaard M; Saketkoo LA; Simon L; Singh JA; Strand V; Tugwell P
    J Rheumatol; 2014 May; 41(5):994-9. PubMed ID: 24634204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set.
    Morillon MB; Nørup A; Singh JA; Dalbeth N; Taylor WJ; Kennedy MA; Pedersen BM; Grainger R; Tugwell P; Perez-Ruiz F; Diaz-Torne C; Edwards NL; Shea B; Ellingsen TJ; Christensen R; Stamp LK;
    Semin Arthritis Rheum; 2023 Jun; 60():152191. PubMed ID: 36963128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting.
    Toupin-April K; Barton J; Fraenkel L; Li LC; Brooks P; De Wit M; Stacey D; Légaré F; Meara A; Shea B; Lyddiatt A; Hofstetter C; Gossec L; Christensen R; Scholte-Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Pohl C; Jull JE; Sivarajah S; Campbell W; Alten R; Karuranga S; Morgan E; Kaufman J; Hill S; Maxwell LJ; Welch V; Beaton D; El-Miedany Y; Tugwell PS
    J Rheumatol; 2017 Oct; 44(10):1544-1550. PubMed ID: 28765239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Classification of Functioning, Disability and Health Core Set construction in systemic sclerosis and other rheumatic diseases: a EUSTAR initiative.
    Saketkoo LA; Escorpizo R; Keen KJ; Fligelstone K; Distler O;
    Rheumatology (Oxford); 2012 Dec; 51(12):2170-6. PubMed ID: 22919048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Draft Core Set of Domains for Measuring Shared Decision Making in Osteoarthritis: An OMERACT Working Group on Shared Decision Making.
    Toupin-April K; Barton J; Fraenkel L; Li L; Grandpierre V; Guillemin F; Rader T; Stacey D; Légaré F; Jull J; Petkovic J; Scholte-Voshaar M; Welch V; Lyddiatt A; Hofstetter C; De Wit M; March L; Meade T; Christensen R; Gaujoux-Viala C; Suarez-Almazor ME; Boonen A; Pohl C; Martin R; Tugwell PS
    J Rheumatol; 2015 Dec; 42(12):2442-7. PubMed ID: 25877502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.
    Kelly A; Tong A; Tymms K; March L; Craig JC; De Vera M; Evans V; Hassett G; Toupin-April K; van den Bemt B; Teixeira-Pinto A; Alten R; Bartlett SJ; Campbell W; Dawson T; Gill M; Hebing R; Meara A; Nieuwlaat R; Shaw Y; Singh JA; Suarez-Almazor M; Sumpton D; Wong P; Christensen R; Beaton D; de Wit M; Tugwell P;
    Trials; 2018 Mar; 19(1):204. PubMed ID: 29587864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology.
    Wolfe F; Lassere M; van der Heijde D; Stucki G; Suarez-Almazor M; Pincus T; Eberhardt K; Kvien TK; Symmons D; Silman A; van Riel P; Tugwell P; Boers M
    J Rheumatol; 1999 Feb; 26(2):484-9. PubMed ID: 9972992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OMERACT Filter Evidence Supporting the Measurement of At-work Productivity Loss as an Outcome Measure in Rheumatology Research.
    Beaton DE; Dyer S; Boonen A; Verstappen SM; Escorpizo R; Lacaille DV; Bosworth A; Gignac MA; Leong A; Purcaru O; Leggett S; Hofstetter C; Peterson IF; Tang K; Fautrel B; Bombardier C; Tugwell PS
    J Rheumatol; 2016 Jan; 43(1):214-22. PubMed ID: 26329339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.